메뉴 건너뛰기




Volumn 26, Issue 1, 2011, Pages 3-11

Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001-2008

Author keywords

COMPLIANCE; FRACTURES; MEDICATION POSSESSION RATIO; ORAL BISPHOSPHONATES; OSTEOPOROSIS

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID;

EID: 78650962009     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.189     Document Type: Article
Times cited : (76)

References (18)
  • 1
    • 78650938318 scopus 로고    scopus 로고
    • National Osteoporosis Foundation Available at: Accessed October 1
    • National Osteoporosis Foundation. Disease statistics. Available at: Accessed October 1, 2009.
    • (2009) Disease Statistics
  • 2
    • 0034530951 scopus 로고    scopus 로고
    • Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    • Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab. 2000; 85: 4118-4124.
    • (2000) J Clin Endocrinol Metab. , vol.85 , pp. 4118-4124
    • Black, D.M.1    Thompson, D.E.2    Bauer, D.C.3
  • 3
    • 4544262219 scopus 로고    scopus 로고
    • Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
    • Chesnut CH III, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004; 19: 1241-1249.
    • (2004) J Bone Miner Res. , vol.19 , pp. 1241-1249
    • Chesnut Iii, C.H.1    Skag, A.2    Christiansen, C.3
  • 4
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
    • Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999; 282: 1344-1352.
    • (1999) JAMA , vol.282 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3
  • 6
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value in Health. 2008; 11: 44-47.
    • (2008) Value in Health. , vol.11 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 7
    • 33746821808 scopus 로고    scopus 로고
    • Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 U.S. claims databases
    • Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 U.S. claims databases. Mayo Clin Proc. 2006; 81: 1013-1022.
    • (2006) Mayo Clin Proc. , vol.81 , pp. 1013-1022
    • Siris, E.S.1    Harris, S.T.2    Rosen, C.J.3
  • 8
    • 50249133642 scopus 로고    scopus 로고
    • Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users
    • Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Deizell E., Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users. JBMR. 2008; 23: 1435-1441.
    • (2008) JBMR , vol.23 , pp. 1435-1441
    • Curtis, J.R.1    Westfall, A.O.2    Cheng, H.3    Lyles, K.4    Saag, K.G.5    Deizell, E.6
  • 9
    • 68949220425 scopus 로고    scopus 로고
    • Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: A population-based study
    • Blouin J, Dragomir A, Fredette M, Ste-Marie LG, Fernandes JC, Perreault S., Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study. Osteoporos Int. 2009; 20: 1571-1581.
    • (2009) Osteoporos Int. , vol.20 , pp. 1571-1581
    • Blouin, J.1    Dragomir, A.2    Fredette, M.3    Ste-Marie, L.G.4    Fernandes, J.C.5    Perreault, S.6
  • 10
    • 73949136942 scopus 로고    scopus 로고
    • Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates
    • Danese MD, Badamgarav E, Bauer DC., Effect of adherence on lifetime fractures in osteoporotic women treated with daily and weekly bisphosphonates. JBMR. 2009; 24: 1819-1826.
    • (2009) JBMR , vol.24 , pp. 1819-1826
    • Danese, M.D.1    Badamgarav, E.2    Bauer, D.C.3
  • 11
    • 68949203799 scopus 로고    scopus 로고
    • Adherence to weekly oral bisphosphonate therapy: Cost of wasted drugs and fractures
    • Sheehy O, Kindundu C, Barbeau M, LeLorier J., Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int. 2009; 20: 1583-1594.
    • (2009) Osteoporos Int. , vol.20 , pp. 1583-1594
    • Sheehy, O.1    Kindundu, C.2    Barbeau, M.3    Lelorier, J.4
  • 12
    • 0029806728 scopus 로고    scopus 로고
    • Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age
    • Baron JA, Karagas M, Barrett J, et al. Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age. Epidemiology. 1996; 7: 612-618.
    • (1996) Epidemiology. , vol.7 , pp. 612-618
    • Baron, J.A.1    Karagas, M.2    Barrett, J.3
  • 14
    • 0028968710 scopus 로고
    • Prevalence of low femoral bone density in older U.S. women from NHANES III
    • Looker AC, Johnston CC, Wahner HW, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. JBMR. 1995; 10: 796-802.
    • (1995) JBMR , vol.10 , pp. 796-802
    • Looker, A.C.1    Johnston, C.C.2    Wahner, H.W.3
  • 16
    • 70350233465 scopus 로고    scopus 로고
    • Incidence and mortality of hip fractures in the United States
    • Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB., Incidence and mortality of hip fractures in the United States. JAMA. 2009; 302: 1573-1579.
    • (2009) JAMA , vol.302 , pp. 1573-1579
    • Brauer, C.A.1    Coca-Perraillon, M.2    Cutler, D.M.3    Rosen, A.B.4
  • 17
    • 0037125875 scopus 로고    scopus 로고
    • Screening for postmenopausal osteoporosis: A review of the evidence for the U.S. Preventive Services Task Force
    • Nelson HD, Helfand M, Woolf SH, Allan JD., Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 529-541. (Pubitemid 35024625)
    • (2002) Annals of Internal Medicine , vol.137 , Issue.6 , pp. 529-541
    • Nelson, H.D.1    Helfand, M.2    Woolf, S.H.3    Allan, J.D.4
  • 18
    • 46549088419 scopus 로고    scopus 로고
    • WHO Collaborating Center for Metabolic Bone Diseases, Sheffield University Sheffield University, Sheffield, UK
    • WHO Collaborating Center for Metabolic Bone Diseases, Sheffield University. Assessment of osteoporosis at the primary health care level. 2008; Sheffield University, Sheffield, UK.
    • (2008) Assessment of Osteoporosis at the Primary Health Care Level


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.